At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.
News|Articles|September 15, 2026
Case Study | How One Brand Used Automated Affordability to Reduce Patient Abandonment
Author(s)CoverMyMeds
Affordability can be the difference between a prescription written and a prescription filled. This case study examines how one brand's automated pharmacy affordability program helped reduce patient cost barriers and what happened when that support was temporarily removed, resulting in higher abandonment rates and fewer filled prescriptions.
Related to this article
Octapharma USA's Kerem Tokel explains how tariffs and DSCSA are affecting how stolen pharma loads are resold, and why partner SOPs matter.
At LogiPharma USA 2026, Mark Talens explains where pharma gains the most from shared distribution visibility.
In this week's Pharma Pulse, PhRMA sues to block CMS's GLOBE pricing model, WFS opens a temperature-controlled cargo terminal in Lyon and Bayer commits $2.2 billion to a new Ohio manufacturing site.
Freehand CEO Nitin Jayakrishnan explains why pharma manufacturers are trading long-term plans for operating models built to sense and pivot.
PhRMA's lawsuit argues CMS overstepped its demonstration authority by tying Medicare Part B rebates to international prices.
At LogiPharma USA 2026, Swisslog's Garrett Freeman explains how onshoring, geopolitical risk and a shifting product mix are driving supply chain automation.
At LogiPharma USA 2026, quality leaders explained why connected data, risk-based prioritization, and human accountability must come before AI in supply chain compliance.
Trending on Pharmaceutical Commerce
1
LogiPharma USA 2026: Data Readiness Must Come Before AI
2
LogiPharma USA 2026: Where Cold Chain Expertise Gaps Become Product Risk
3
Why PhRMA Sued to Block Medicare's GLOBE Pricing Model
4
Why Securing Pharma Freight Starts With Broker and Carrier SOPs
5